Response to: The BRAIN TRIAL: a randomized, placebo controlledtrial of a Bradykinin B2 receptor antagonist (Anatibant) in patientswith traumatic brain injury - authors' reply.
Saved in:
| Title: | Response to: The BRAIN TRIAL: a randomized, placebo controlledtrial of a Bradykinin B2 receptor antagonist (Anatibant) in patientswith traumatic brain injury - authors' reply. |
|---|---|
| Source: | Trials. 2009, Vol. 10, p1-2. 2p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
